The Prevention Community of Practice (CoP) provides an opportunity for Federally Qualified Community Health Centers (FHQCs) in Philadelphia, Baltimore, and Washington, DC to learn from each other regarding increasing HIV testing, diagnosis, and prevention, including the provision of pre-exposure prophylaxis (PrEP). Health Resources and Services Administration’s (HRSA) Bureau of Primary Care and HIV/AIDS Bureau are supporting this initiative to partner with Ending the HIV Epidemic-funded FQHCs in the MAAETC region.
Shanna Dell, BS, BSN, RN from the Moore Clinic at Johns Hopkins Hospital will review latest updates to PrEP clinical guidelines, including the injectable formulation cabotegravir.
Learning Objectives:
As a result of attending this program, participants should be able to:
- List clinical considerations for oral and injectable PrEP medications
- Apply lessons learned to their work setting
- Incorporate quality improvement measures to increase PrEP implementation at their site
CME and nursing credits will be available.
Faculty and program planners have no financial disclosures.
